Provided by Tiger Trade Technology Pte. Ltd.

Cogent

7.94
+0.15001.93%
Volume:594.43K
Turnover:4.61M
Market Cap:406.65M
PE:-8.43
High:8.01
Open:7.83
Low:7.43
Close:7.79
52wk High:45.69
52wk Low:7.13
Shares:51.22M
Float Shares:45.32M
Volume Ratio:0.78
T/O Rate:1.31%
Dividend:0.08
Dividend Rate:1.01%
EPS(TTM):-0.9421
EPS(LYR):-3.8009
ROE:-721.50%
ROA:-1.24%
PB:-11.91
PE(LYR):-2.09

Loading ...

Cogent Comms Amends Indenture to Prioritize Debt Reduction

TIPRANKS
·
Jun 16

Cogent Communications VP of Network Strategy Hank Kilmer disposes of 2,400 common shares worth $40,824

Reuters
·
Jun 16

Cogent Communications amends indenture, raises ratio-liens secured leverage cap to 4.75x

Reuters
·
Jun 16

Cogent Biosciences' Potential Rare Blood Disease Treatment Meets Endpoints in Clinical Trial

MT Newswires Live
·
Jun 12

Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress

GlobeNewswire
·
Jun 12

Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress

GlobeNewswire
·
Jun 12

Cogent Biosciences Shareholders Back Board, Governance Proposals

TIPRANKS
·
Jun 12

A Look At Cogent Communications Holdings (CCOI) Valuation After Recent Share Price Weakness

Simply Wall St.
·
Jun 01

Cogent Biosciences announces data from analysis of PEAK Phase 3 trial

TIPRANKS
·
Jun 01

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire
·
May 30

Cogent Communications Shares Fall After JPMorgan Downgrade

MT Newswires Live
·
May 30

Cogent Biosciences Price Target Maintained With a $55.00/Share by Wedbush

Dow Jones
·
May 29

Cogent Communications Cut to Neutral From Overweight by JP Morgan

Dow Jones
·
May 29

JPMorgan Downgrades Cogent Communications to Neutral From Overweight, $22 Price Target

MT Newswires Live
·
May 29

U.S. RESEARCH ROUNDUP-Autodesk, Dell Technologies, Hyatt Hotels

Reuters
·
May 29

Cogent Communications Holdings Inc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS
·
May 29

Cogent downgraded to Neutral from Overweight at JPMorgan

TIPRANKS
·
May 29

Cogent Communications director Lewis Ferguson disposes of 2,800 common shares worth $57,008

Reuters
·
May 29

Cogent Biosciences announces FDA acceptance of bezuclastinib NDA

TIPRANKS
·
May 28

Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST

GlobeNewswire
·
May 28